Astragaloside IV Global Market Size Forecast Top 12 Player - Maharashtra - Navi Mumbai ID1548657

Astragaloside IV is the main active ingredient of Astragalus membranaceus. It was discovered through in-depth research on the pharmacological effects of Astragaloside IV. It has immune regulation, ischemia protection, cardiac protection, anti-inflammatory, anti-viral and anti-tumor effects. Astragaloside IV is available in various specifications: brown powder (0.3%, 1%, 5%, 10%), light yellow powder (70%, 90%), white powder (98%). The price ranges from tens of dollars to thousands of dollars depending on the content.

According to the new market research report "Global Astragaloside IV Market Report 2023-2029", published by QYResearch, the global Astragaloside IV market size is projected to grow from USD 11.34 million in 2023 to USD 15.33 million by 2029, at a CAGR of 4.8% during the forecast period.

Market Drivers:

1. People’s demand for natural, healthy foods and health products is increasing, which has brought huge development opportunities to the Astragaloside IV industry.

2. The demand for traditional Chinese medicine and natural herbal medicine is growing globally, especially in Europe and the United States, and the demand for Astragaloside IV is also gradually increasing, which provides opportunities for Chinese companies to explore the international market.

3. The government's support for the traditional Chinese medicine industry continues to increase.

Restraints:

1. As the industry develops, competitors continue to increase. Intensified market competition may lead to product prices falling and profit margins being compressed.

2. The industry is affected by domestic and foreign regulatory policies. Changes in policies and regulations affect production, import, export and market access, increasing the uncertainty of industry operations.

3. There are different cultures, regulations and trade barriers in the international market, and international market expansion faces challenges in language, brand recognition and other aspects.

Opportunities:

1 . The continuous progress of modern biotechnology and separation and purification technology will promote the technological upgrading and product quality improvement of the Astragaloside IV industry.

2. The industry will strengthen the construction of quality control systems and improve product quality standards to meet the strict requirements of the international market for product quality.

For more information, please contact the following e-mail address:
Email: global@qyresearch.com
Website: https://www.qyresearch.com

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.